MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Colorectal cancer (CRC) remains a leading cause of cancer mortality globally, with therapy resistance and recurrence posing significant challenges.
• Deregulation of hormone signaling pathways and their interactions with intracellular cascades are implicated in CRC treatment resistance.
• MicroRNAs (miRNAs), small non-coding RNAs, are recognized regulators of gene expression and have been linked to cancer progression and drug resistance.

Purpose of the Study:

• To comprehensively review and assess the role of miRNAs in hormone signaling pathways within the context of CRC drug resistance.
• To evaluate the potential of miRNAs as therapeutic targets for overcoming resistance to CRC treatments.

Main Methods:

• Literature review and synthesis of existing research on miRNAs, hormone signaling, and CRC drug resistance.
• Analysis of studies identifying miRNA alterations in cancer progression and drug resistance.
• Assessment of the interplay between miRNAs and hormone signaling pathways in mediating resistance.

Main Results:

• miRNA alterations are frequently observed in colorectal cancer, influencing gene expression and contributing to therapeutic resistance.
• Specific miRNAs play critical roles in modulating hormone signaling pathways, thereby affecting CRC cell sensitivity to treatments.
• The cross-talk between miRNAs and hormone signaling pathways represents a significant mechanism driving drug resistance in CRC.

Conclusions:

• miRNAs are pivotal in regulating hormone signaling pathways implicated in colorectal cancer drug resistance.
• Targeting specific miRNAs involved in these pathways presents a promising strategy for developing novel therapeutic approaches to overcome CRC treatment resistance.
• Further research into miRNA-mediated hormone signaling is essential for advancing CRC therapy and improving patient outcomes.